EUVIMEDEUVIMED entdecken
Open Access

Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease

Andrea G Cogal, Ahmed E Ali iD, Muhammad G Arnous iD, Abdulmueti Alhadi iD, Le-Ting Zhou iD, Jennifer Arroyo iD, Barbara M Seide iD, Kalina J Rossler iD, Laura M Reynolds iD, Gabrielle N Kennedy iD, Doaa E Elbarougy iD, David S Goldfarb iD und 5 weitere

Clinical Journal of the American Society of Nephrology · 2025-12 · 20 (12) · 1670-1682

DOI: 10.2215/cjn.0000000817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 12.08.2025. Verfasst von Andrea G Cogal und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Rare Kidney Stone Consortium.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Genetic testing of individuals suspected of monogenic urinary stone disease resolved 34% of families with 22 different genes detected. Resolved individuals had a lower baseline and last visit eGFR and earlier age of stone presentation than the unresolved group. Specific phenotypes and younger diagnostic age were associated with a monogenic cause, allowing refinement of future screenings.

Background

Urinary stone disease with a clear genetic cause, monogenic stone disease (MSD), is increasingly recognized as a significant proportion of the total population. When MSD is suspected, genetic testing provides a firm diagnosis that can alter management and treatment. Here, we present testing results from a large cohort with suspected MSD.

Methods

Patients with features suggestive of MSD (early onset, family history, frequent stones, nephrocalcinosis [NC], and/or CKD) were recruited by the Rare Kidney Stone Consortium and genotyped for up to 160 known or candidate MSD genes via a targeted massively parallel sequencing panel. We compared clinical and biochemical features between genetically resolved MSD and unresolved individuals.

Results

Of 426 families (657 patients) enrolled, 145 (34%) were resolved with identified disease associated variants in 22 known MSD genes. Ninety-nine families were biallelic, 37 monoallelic, and two digenic. An additional 21 of the 231 screened family members were resolved. Genes identified in ten or more families include the following: AGXT , HOGA1 , SLC34A3 , CYP24A1 , SLC3A1 , and CLCN5 . Compared with the unresolved group, MSD probands had a lower baseline and last visit eGFR, earlier age of stone presentation, and more stone events and procedures/year of life. The resolve rate was higher in those

Schlagwörter

Stichwörter der Autor:innen

CKDgenetics and development

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
  • Wuxi People's Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
  • Nephrology Division, New York University Langone Health and New York University School of Medicine, New York, New York.
  • Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: Ahmed E Ali, Muhammad G Arnous, Abdulmueti Alhadi, Le-Ting Zhou, Jennifer Arroyo, Barbara M Seide, Kalina J Rossler, Laura M Reynolds, Gabrielle N Kennedy, Doaa E Elbarougy, David S Goldfarb, Dawn S Milliner, John C Lieske, Peter C Harris

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Rare Kidney Stone Consortium
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NCATS
  • Oxalosis and Hyperoxaluria Foundation

Zitieren

APA

Cogal, A. G., Ali, A. E., Arnous, M. G., Alhadi, A., Zhou, L. T., Arroyo, J., Seide, B. M., Rossler, K. J., Reynolds, L. M., Kennedy, G. N., Elbarougy, D. E., Goldfarb, D. S., Milliner, D. S., Sas, D. J., Lieske, J. C., Harris, P. C., & Investigators of the Rare Kidney Stone Consortium (2025). Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease. Clinical Journal of the American Society of Nephrology, 20(12), 1670-1682. https://doi.org/10.2215/cjn.0000000817

Vancouver

Cogal AG, Ali AE, Arnous MG, Alhadi A, Zhou LT, Arroyo J, et al. Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease. Clinical Journal of the American Society of Nephrology. 2025;20(12):1670-1682. doi:10.2215/cjn.0000000817

BibTeX
@article{Cogal2025,
  author = {Cogal, Andrea G and Ali, Ahmed E and Arnous, Muhammad G and Alhadi, Abdulmueti and Zhou, Le-Ting and Arroyo, Jennifer and Seide, Barbara M and Rossler, Kalina J and Reynolds, Laura M and Kennedy, Gabrielle N and Elbarougy, Doaa E and Goldfarb, David S and Milliner, Dawn S and Sas, David J and Lieske, John C and Harris, Peter C and Investigators of the Rare Kidney Stone Consortium, Investigators of the Rare Kidney Stone Consortium},
  title = {Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2025},
  volume = {20},
  number = {12},
  pages = {1670--1682},
  doi = {10.2215/cjn.0000000817}
}
Kostenlos starten →